SynthesisSchizophrenia bulletin2026
Gray Matter Volume Abnormalities in Schizophrenia: Comparisons Between P-Value and Effect Size Inference Frameworks Using Mega- and Meta-Analyses.
Synthesis in Schizophrenia bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
Abstract
background and hypothesisIdentifying generalizable brain imaging markers from large multi-center datasets remains challenging due to varying statistical aggregation approaches and p-hacking with increasing big data. We hypothesized that effect size (ES) inference surpasses P-value-based inference in reliably identifying core brain damage of schizophrenia, regardless of whether Mega- or Meta-analyses are used. STUDY
designWe examined voxel-wise inter-group differences in gray matter volume (GMV) based on individual data from 976 schizophrenia patients and 801 healthy controls across 16 datasets, along with published coordinates data from 103 studies involving 5151 patients and 5438 controls, using Mega-analysis (Mega), Image-Based Meta-analysis (IBMA), and Coordinate-Based Meta-analysis (CBMA) under P-value and ES inference frameworks, respectively. We then compared the performances of different statistical aggregation (Mega, IBMA, and CBMA) and statistical inference (P-value and ES) strategies in revealing brain abnormalities in schizophrenia. STUDY
resultsP-value Mega identified significant GMV abnormalities in nearly all gray matter voxels (94.85%) with high sensitivity to sample size; in contrast, ES Mega detected core abnormalities in only 24.63% of voxels that had large ES and manifested higher resistance to sample size. ES IBMA and CBMA also demonstrated superior detection performance and were less affected by sample size than P-value ones. Finally, IBMA exhibited comparable performance with the Mega-analysis and superior performance than all types of CBMAs.
conclusionsThese results underscore the advantages of using ES inference in multi-center statistical aggregation and highlight the potential of IBMA for enhanced detection of brain structural abnormalities in schizophrenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.